Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative
Pharmacogenetics (PGx) has the potential to improve opioid medication management. Here, we present patient perception data, pharmacogenetic data and medication management trends in patients with chronic pain (arm 1) and opioid use disorder (arm 2) treated at Cooper University Health Care in Camden C...
Main Authors: | Dara Kusic, Jessica Heil, Stefan Zajic, Andrew Brangan, Oluseun Dairo, Gretchen Smith, Diego Morales-Scheihing, Russell J. Buono, Thomas N. Ferraro, Rachel Haroz, Matthew Salzman, Kaitlan Baston, Elliot Bodofsky, Michael Sabia, Alissa Resch, Laura B. Scheinfeldt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/9/1863 |
Similar Items
-
Postmortem toxicology findings from the Camden Opioid Research Initiative.
by: Dara M Kusic, et al.
Published: (2023-01-01) -
Postmortem toxicology findings from the Camden Opioid Research Initiative
by: Dara M. Kusic, et al.
Published: (2023-01-01) -
Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
by: Icro Maremmani, et al.
Published: (2023-08-01) -
Linking the gut microbiome to microglial activation in opioid use disorder
by: Danielle Antoine, et al.
Published: (2022-12-01) -
Editorial: Opioids and opioid-use disorders
by: Giordano de Guglielmo, et al.
Published: (2023-06-01)